Combination Therapy with Glucan and Coenzyme Q^sub 10^ in Murine Experimental Autoimmune Disease and Cancer

Background/Aim: Coenzyme Q10 is a well-accepted anti-oxidant agent known to play a protective role in various physiological and disease processes. Recently, Coenzyme Q10 is gaining attention as a substance with significant anti-inflammatory properties. β-Glucan is the most studied immunomodulator wi...

Full description

Saved in:
Bibliographic Details
Published in:Anticancer research 2018-06, Vol.38 (6), p.3291
Main Authors: Vetvicka, Vaclav, Vetvickova, Jana
Format: Article
Language:English
Subjects:
Anti-inflammatory agents
Anticancer properties
Cancer
Coenzyme Q
Coenzyme Q10
Glucan
In vivo methods and tests
Inflammation
Phagocytosis
Synergistic effect
β-Glucan
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background/Aim: Coenzyme Q10 is a well-accepted anti-oxidant agent known to play a protective role in various physiological and disease processes. Recently, Coenzyme Q10 is gaining attention as a substance with significant anti-inflammatory properties. β-Glucan is the most studied immunomodulator with significant synergetic effects with numerous bioactive molecules. We aimed to evaluate the possible synergistic effects of simultaneous use of coenzyme Q10 with the well-established immune modulator, β-glucan, on immune reactions and cancer development. Materials and Methods: Coenzyme Q10 and β-glucan were used, both in vivo and in vitro, and their effects were evaluated using phagocytosis and cytokine secretion. Results: Our study confirmed the strong anti-inflammatory effects of coenzyme Q10 and showed that these effects were further potentiated with the addition of β-glucan. The anticancer effects of coenzyme Q10 were less pronounced, but stronger, with the addition of β-glucan. Conclusion: There is significant synergy between coenzyme Q10 and β-glucan.
ISSN:0250-7005
1791-7530